2021 Q4 Form 10-Q Financial Statement

#000159597421000066 Filed on November 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2021 Q2
Revenue $161.3M $131.9M $114.5M
YoY Change 96.68% 116.25% 170.48%
Cost Of Revenue $66.84M $63.54M $50.53M
YoY Change 215.75% 202.13% 134.51%
Gross Profit $94.45M $68.33M $64.02M
YoY Change 55.25% 71.03% 207.72%
Gross Profit Margin 58.56% 51.82% 55.89%
Selling, General & Admin $45.81M $68.80M $60.25M
YoY Change 21.4% 96.14% 68.26%
% of Gross Profit 48.5% 100.68% 94.12%
Research & Development $20.81M $21.06M $18.11M
YoY Change 46.24% 55.28% 38.64%
% of Gross Profit 22.03% 30.82% 28.29%
Depreciation & Amortization $49.80M $48.70M $35.89M
YoY Change 280.46% 245.89% 146.51%
% of Gross Profit 52.73% 71.27% 56.07%
Operating Expenses $90.41M $89.85M $78.36M
YoY Change 73.99% 84.74% 60.35%
Operating Profit $4.034M -$23.95M -$46.98M
YoY Change -49.54% 118.9% 15.83%
Interest Expense -$7.131M -$6.034M -$5.045M
YoY Change 127.83% 1785.63% -1246.59%
% of Operating Profit -176.77%
Other Income/Expense, Net $1.133M -$5.079M -$3.906M
YoY Change -158.13% -683.12% -326.83%
Pretax Income -$2.363M -$29.03M -$50.89M
YoY Change -139.08% 188.28% 31.02%
Income Tax -$2.816M -$4.700M -$87.70M
% Of Pretax Income
Net Earnings $453.0K -$24.32M $36.81M
YoY Change -92.3% 131.28% -194.07%
Net Earnings / Revenue 0.28% -18.44% 32.14%
Basic Earnings Per Share -$0.18 $0.29
Diluted Earnings Per Share $3.427K -$0.18 $0.26
COMMON SHARES
Basic Shares Outstanding 131.8M shares 131.5M shares 126.0M shares
Diluted Shares Outstanding 131.5M shares 143.0M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $230.4M $188.2M $193.0M
YoY Change 95.75% 81.29% 79.51%
Cash & Equivalents $230.4M $188.2M $193.0M
Short-Term Investments
Other Short-Term Assets $19.93M $20.99M $30.56M
YoY Change 12.62% 56.66% 196.7%
Inventory
Prepaid Expenses
Receivables $927.8M $765.1M $780.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.178B $974.3M $1.004B
YoY Change 94.07% 83.96% 144.77%
LONG-TERM ASSETS
Property, Plant & Equipment $34.07M $32.76M $34.43M
YoY Change 43.86% 73.55% 74.72%
Goodwill $969.9M $972.7M $945.7M
YoY Change 513.38% 516.41% 499.3%
Intangibles $426.6M $463.6M $483.9M
YoY Change 374.63% 377.26% 361.02%
Long-Term Investments
YoY Change
Other Assets $6.862M $6.062M $6.893M
YoY Change 54.55% 106.05% 102.56%
Total Long-Term Assets $1.534B $1.559B $1.537B
YoY Change 362.35% 362.74% 343.09%
TOTAL ASSETS
Total Short-Term Assets $1.178B $974.3M $1.004B
Total Long-Term Assets $1.534B $1.559B $1.537B
Total Assets $2.713B $2.533B $2.541B
YoY Change 188.9% 192.35% 235.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $983.1M $806.5M $820.1M
YoY Change 97.85% 81.49% 142.85%
Accrued Expenses $36.97M $36.99M $39.31M
YoY Change 65.8% 52.83% 80.31%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.600M $3.600M $3.600M
YoY Change
Total Short-Term Liabilities $1.029B $858.9M $873.7M
YoY Change 97.13% 81.35% 141.12%
LONG-TERM LIABILITIES
Long-Term Debt $720.0M $719.3M $718.6M
YoY Change
Other Long-Term Liabilities $2.647M $2.618M $2.854M
YoY Change -0.94% 5.65% 5.31%
Total Long-Term Liabilities $722.7M $722.0M $721.5M
YoY Change 26946.03% 29034.42% 26523.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.029B $858.9M $873.7M
Total Long-Term Liabilities $722.7M $722.0M $721.5M
Total Liabilities $1.832B $1.656B $1.654B
YoY Change 228.67% 224.56% 313.76%
SHAREHOLDERS EQUITY
Retained Earnings -$394.5M -$394.9M -$370.6M
YoY Change -0.02% -1.37% -4.95%
Common Stock $2.000K $2.000K $2.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $6.007M
YoY Change
Treasury Stock Shares 349.0K shares
Shareholders Equity $880.8M $876.8M $887.7M
YoY Change
Total Liabilities & Shareholders Equity $2.713B $2.533B $2.541B
YoY Change 188.9% 192.35% 235.65%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2021 Q2
OPERATING ACTIVITIES
Net Income $453.0K -$24.32M $36.81M
YoY Change -92.3% 131.28% -194.07%
Depreciation, Depletion And Amortization $49.80M $48.70M $35.89M
YoY Change 280.46% 245.89% 146.51%
Cash From Operating Activities $68.59M $30.59M $28.64M
YoY Change 473.01% -1304.29% -276.04%
INVESTING ACTIVITIES
Capital Expenditures -$6.618M -$6.393M -$12.85M
YoY Change -39.0% 115.25% 263.94%
Acquisitions
YoY Change
Other Investing Activities -$8.809M -$29.09M -$624.0M
YoY Change -1242.81%
Cash From Investing Activities -$15.43M -$35.48M -$636.8M
YoY Change 42.18% 1094.58% -1346.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.81M 582.0K 332.7M
YoY Change -201.69% -62.69% 12596.6%
NET CHANGE
Cash From Operating Activities 68.59M 30.59M 28.64M
Cash From Investing Activities -15.43M -35.48M -636.8M
Cash From Financing Activities -10.81M 582.0K 332.7M
Net Change In Cash 42.35M -4.308M -275.5M
YoY Change 260.44% 9.06% -836.31%
FREE CASH FLOW
Cash From Operating Activities $68.59M $30.59M $28.64M
Capital Expenditures -$6.618M -$6.393M -$12.85M
Free Cash Flow $75.21M $36.98M $41.49M
YoY Change 229.57% 8500.47% -425.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001595974
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q3 mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36384
dei Entity Registrant Name
EntityRegistrantName
MAGNITE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-8881738
dei Entity Address Address Line1
EntityAddressAddressLine1
1250 Broadway,
dei Entity Address Address Line2
EntityAddressAddressLine2
15th Floor
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
243-2769
dei Security12b Title
Security12bTitle
Common stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
MGNI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
131812867 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188182000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
117676000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
765076000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
471666000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20992000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17729000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
974250000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
607071000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32759000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23681000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
64591000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39599000 USD
CY2021Q3 mgni Internal Use Software Development Costs Net
InternalUseSoftwareDevelopmentCostsNet
19130000 USD
CY2020Q4 mgni Internal Use Software Development Costs Net
InternalUseSoftwareDevelopmentCostsNet
16160000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
463571000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
89884000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6062000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4440000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
972747000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
158125000 USD
CY2021Q3 us-gaap Assets
Assets
2533110000 USD
CY2020Q4 us-gaap Assets
Assets
938960000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3070000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
858907000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
522198000 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
828501000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
509315000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
15033000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9813000 USD
CY2021Q3 us-gaap Debt Current
DebtCurrent
3600000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
0 USD
CY2021Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11773000 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
719333000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
19488000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
199000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
55999000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32278000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2618000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2672000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1656345000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
557347000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131789000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131789000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114029000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114029000 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1273093000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
777084000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1426000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-957000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394904000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-394516000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
876765000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
381613000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2533110000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
938960000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131871000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60982000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
307127000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139625000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
63541000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
21031000 USD
us-gaap Cost Of Revenue
CostOfRevenue
134823000 USD
us-gaap Cost Of Revenue
CostOfRevenue
56579000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52260000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21761000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
118122000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
53059000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21059000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13562000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53436000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
37318000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16535000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13314000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47673000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38221000 USD
CY2021Q3 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
2424000 USD
CY2020Q3 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
2254000 USD
mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
37778000 USD
mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
16677000 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
155819000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
71922000 USD
us-gaap Costs And Expenses
CostsAndExpenses
391832000 USD
us-gaap Costs And Expenses
CostsAndExpenses
201854000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-23948000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-10940000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-84705000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-62229000 USD
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7280000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-30000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-12595000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
112000 USD
CY2021Q3 us-gaap Other Operating Income
OtherOperatingIncome
955000 USD
CY2020Q3 us-gaap Other Operating Income
OtherOperatingIncome
1194000 USD
us-gaap Other Operating Income
OtherOperatingIncome
3317000 USD
us-gaap Other Operating Income
OtherOperatingIncome
2487000 USD
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1246000 USD
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-293000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1358000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
845000 USD
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5079000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
871000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7920000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3444000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29027000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10069000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92625000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-58785000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4708000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
446000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-92237000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
533000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-24319000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10515000 USD
us-gaap Net Income Loss
NetIncomeLoss
-388000 USD
us-gaap Net Income Loss
NetIncomeLoss
-59318000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131501000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131501000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110416000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110416000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124325000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124325000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91371000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
91371000 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-24319000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-469000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2540000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10515000 USD
us-gaap Net Income Loss
NetIncomeLoss
-388000 USD
us-gaap Net Income Loss
NetIncomeLoss
-59318000 USD
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-525000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
18000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-525000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
18000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-469000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2540000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24844000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10497000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-857000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-61858000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
111936000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
23000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7485000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4218000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-789000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-9675000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
98228000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2276000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
693000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
349000 USD
CY2020Q2 mgni Stock Issued During Period Value Merger
StockIssuedDuringPeriodValueMerger
275773000 USD
CY2020Q2 mgni Share Based Payment Arrangement Exchange Of Stock And Restricted Stock Units In Merger
ShareBasedPaymentArrangementExchangeOfStockAndRestrictedStockUnitsInMerger
11646000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10101000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1769000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-39128000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
357471000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1569000 USD
CY2020Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
7000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7595000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
18000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10515000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
356131000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
381613000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5785000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7108000 USD
CY2021Q1 mgni Apic Share Based Payment Arrangement Decrease For Capped Calls
APICShareBasedPaymentArrangementDecreaseForCappedCalls
38960000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-313000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-12877000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
342356000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1480000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1154000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
495591000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9928000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
369000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1482000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
36808000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
887686000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12441000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-525000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-24319000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
876765000 USD
us-gaap Net Income Loss
NetIncomeLoss
-388000 USD
us-gaap Net Income Loss
NetIncomeLoss
-59318000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
97084000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
36157000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
28521000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
21298000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-78000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
17000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
217000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
31000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3223000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
mgni Non Cash Lease Expense
NonCashLeaseExpense
1825000 USD
mgni Non Cash Lease Expense
NonCashLeaseExpense
-601000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-91540000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
837000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2578000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2108000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
92131000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
92131000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
46145000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
297000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2896000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
113795000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
23464000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
191000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5260000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13985000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4211000 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
8525000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24038000 USD
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6894000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
653060000 USD
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
54595000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-675570000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
43490000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
400000000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
349200000 USD
us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
0 USD
mgni Payments For Capped Call Options
PaymentsForCappedCallOptions
38960000 USD
mgni Payments For Capped Call Options
PaymentsForCappedCallOptions
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
30378000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8747000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3868000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1154000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
693000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
900000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7841000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
688863000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3280000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-591000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
70702000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16213000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117731000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
88888000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188433000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105101000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
188182000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103797000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
251000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
1304000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
188433000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105101000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
1221000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
829000 USD
us-gaap Interest Paid Net
InterestPaidNet
7671000 USD
us-gaap Interest Paid Net
InterestPaidNet
49000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1513000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2388000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
956000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
616000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
22651000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2036000 USD
mgni Business Combination Consideration Transferred Indemnification Claims Holdback
BusinessCombinationConsiderationTransferredIndemnificationClaimsHoldback
1409000 USD
mgni Business Combination Consideration Transferred Indemnification Claims Holdback
BusinessCombinationConsiderationTransferredIndemnificationClaimsHoldback
0 USD
us-gaap Stock Issued1
StockIssued1
495591000 USD
us-gaap Stock Issued1
StockIssued1
287418000 USD
mgni Debt Discount Received During Noncash Or Partial Noncash Transaction
DebtDiscountReceivedDuringNoncashOrPartialNoncashTransaction
10800000 USD
mgni Debt Discount Received During Noncash Or Partial Noncash Transaction
DebtDiscountReceivedDuringNoncashOrPartialNoncashTransaction
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported and disclosed financial statements and accompanying footnotes. Due to the economic uncertainty as a result of the COVID-19 pandemic, it has become more difficult to apply certain assumptions and judgments into these estimates. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The extent of the impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">pandemic on the Company's operational and financial performance will depend on future developments, which are highly uncertain and cannot be predicted, including but not limited to, the duration and spread of the pandemic, its severity, including any resurgence, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. During the nine months ended September 30, 2021, this uncertainty continued to result in a higher level of judgment related to its estimates and assumptions. As of the date of issuance of the condensed consolidated financial statements for the three and nine months ended September 30, 2021, the Company is not aware of any specific event or circumstance that would require the Company to update its estimates, judgments, or revise the carrying value of its assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and are recognized in the consolidated financial statements as soon as they become known. Actual results could differ materially from these estimates.</span></div>
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-24319000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-10515000 USD
us-gaap Net Income Loss
NetIncomeLoss
-388000 USD
us-gaap Net Income Loss
NetIncomeLoss
-59318000 USD
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131501000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110416000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124325000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91371000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131501000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110416000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124325000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
91371000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14837000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5732000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15332000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5617000 shares
CY2021Q3 mgni Percent Of Revenue Gross Basis
PercentOfRevenueGrossBasis
0.03
mgni Revenue Payment Terms
RevenuePaymentTerms
P75D
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4000000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131871000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60982000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
307127000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139625000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131871000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60982000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
307127000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139625000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131871000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
60982000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
307127000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139625000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
35000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2400000 USD
CY2021Q3 mgni Accounts Payable Seller
AccountsPayableSeller
2200000 USD
CY2020Q4 mgni Accounts Payable Seller
AccountsPayableSeller
1500000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3279000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4672000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2360000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3400000 USD
CY2021Q3 mgni Accounts Receivable Allowance For Credit Loss Merger Assumed
AccountsReceivableAllowanceForCreditLossMergerAssumed
425000 USD
CY2020Q3 mgni Accounts Receivable Allowance For Credit Loss Merger Assumed
AccountsReceivableAllowanceForCreditLossMergerAssumed
0 USD
mgni Accounts Receivable Allowance For Credit Loss Merger Assumed
AccountsReceivableAllowanceForCreditLossMergerAssumed
835000 USD
mgni Accounts Receivable Allowance For Credit Loss Merger Assumed
AccountsReceivableAllowanceForCreditLossMergerAssumed
1033000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
14000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1897000 USD
CY2021Q3 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
342000 USD
CY2020Q3 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-274000 USD
mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
852000 USD
mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
1854000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
83000 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
20000 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
90000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4032000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4480000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4032000 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4480000 USD
CY2021Q3 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
300000 USD
mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
900000 USD
mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
-600000 USD
CY2021Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
400000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
200000 USD
CY2020Q3 mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
-300000 USD
mgni Accounts Receivable Credit Loss Expense Reversal Gross
AccountsReceivableCreditLossExpenseReversalGross
1900000 USD
CY2020Q3 mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
-300000 USD
mgni Increase Decreasein Accounts Payable Seller
IncreaseDecreaseinAccountsPayableSeller
1800000 USD
CY2021Q3 mgni Accounts Payable Seller Current
AccountsPayableSellerCurrent
791227000 USD
CY2020Q4 mgni Accounts Payable Seller Current
AccountsPayableSellerCurrent
492605000 USD
CY2021Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
15321000 USD
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
4268000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20544000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12442000 USD
CY2021Q3 mgni Indemnification Claim Accrual Current
IndemnificationClaimAccrualCurrent
1409000 USD
CY2020Q4 mgni Indemnification Claim Accrual Current
IndemnificationClaimAccrualCurrent
0 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
828501000 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
509315000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
300000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
100000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
972700000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
158100000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
576708000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
123708000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
113137000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33824000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
463571000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
89884000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42200000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7800000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
79300000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16900000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
42527000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
147361000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
101996000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
84218000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
66668000 USD
CY2021Q3 mgni Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
20801000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
463571000 USD
CY2021Q2 us-gaap Share Price
SharePrice
49.21
CY2021Q2 us-gaap Share Price
SharePrice
40.05
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1064000 USD
CY2020Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
952000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
28032000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9533000 USD
CY2021Q3 mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
48000 USD
CY2020Q3 mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
354000 USD
mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
1070000 USD
mgni Restructuring Reserve And Merger Related Costs Settled Without Cash
RestructuringReserveAndMergerRelatedCostsSettledWithoutCash
1554000 USD
CY2021Q3 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
2424000 USD
CY2020Q3 mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
2254000 USD
mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
37778000 USD
mgni Restructuring Charges And Business Combination Acquisition Related Costs
RestructuringChargesAndBusinessCombinationAcquisitionRelatedCosts
16677000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
12968404 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6695000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
302000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
38.99
mgni Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Gross
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodGross
1393000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.28
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
306000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
8.87
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5298000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M14D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
113430000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3768000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.51
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M25D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
84758000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11824000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7350000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28521000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21298000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4700000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-92200000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
500000 USD
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
4900000 USD
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
3700000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
15700000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
9700000 USD
CY2021Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000 USD
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
400000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
1000000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
800000 USD
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
1000000 USD
CY2020Q3 us-gaap Sublease Income
SubleaseIncome
1200000 USD
us-gaap Sublease Income
SubleaseIncome
3300000 USD
us-gaap Sublease Income
SubleaseIncome
2500000 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0505
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y4M2D
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4093000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
18645000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
15193000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12868000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7286000 USD
CY2021Q3 mgni Lessee Operating Lease Liability To Be Paid Due After Year Four
LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
25921000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
84006000 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12974000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
71032000 USD
CY2021Q1 mgni Debt Instruments Capped Calls Transaction Costs
DebtInstrumentsCappedCallsTransactionCosts
39000000 USD
CY2021Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
11400000 USD
CY2021Q2 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
27700000 USD

Files In Submission

Name View Source Status
0001595974-21-000066-index-headers.html Edgar Link pending
0001595974-21-000066-index.html Edgar Link pending
0001595974-21-000066.txt Edgar Link pending
0001595974-21-000066-xbrl.zip Edgar Link pending
exhibit311q32021.htm Edgar Link pending
exhibit312q32021.htm Edgar Link pending
exhibit32q32021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mgni-20210930.htm Edgar Link pending
mgni-20210930.xsd Edgar Link pending
mgni-20210930_cal.xml Edgar Link unprocessable
mgni-20210930_def.xml Edgar Link unprocessable
mgni-20210930_htm.xml Edgar Link completed
mgni-20210930_lab.xml Edgar Link unprocessable
mgni-20210930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending